Results 21 to 30 of about 22,506 (225)

СРАВНИТЕЛЬНЫЙ АНАЛИЗ КЛИНИКО- ЭКОНОМИЧЕСКОЙ ЭФФЕКТИВНОСТИ МЕТОДОВ РЕПЕРФУЗИОННОЙ ТЕРАПИИ ПРИ ИНФАРКТЕ МИОКАРДА

open access: yesАрхивъ внутренней медицины, 2015
The comparative valuation of efficiency of the different reperfusion therapy methods was carried out in the patients with myocardial infarction using clinico-economical indices.
А. М. Назаров
doaj   +1 more source

Evaluation of fibrinolytic and antioxidant effects of Allium affine hydroalcoholic extract

open access: yesResearch in Pharmaceutical Sciences, 2017
Allium affine is a member of Amaryllidaceae family, which grows wildly in some western regions of Iran. Limited information is available about the pharmacological activities of this plant.
Masoud Sadeghi   +3 more
doaj   +1 more source

Non-sterile Submerged Fermentation of Fibrinolytic Enzyme by Marine Bacillus subtilis Harboring Antibacterial Activity With Starvation Strategy

open access: yesFrontiers in Microbiology, 2019
Microbial fibrinolytic enzyme is a promising candidate for thrombolytic therapy. Non-sterile production of fibrinolytic enzyme by marine Bacillus subtilis D21-8 under submerged fermentation was realized at a mild temperature of 34°C, using a unique ...
Shihan Pan   +4 more
doaj   +1 more source

Food Origin Fibrinolytic Enzyme With Multiple Actions

open access: yesHayati Journal of Biosciences, 2018
Many health related problems such as cardiovascular diseases are associated with the formation of excessive clot in the blood (thrombus). Approaches in cardiovascular disease treatment are preventing the formation or removing the thrombus.
Laurentia Stephani   +5 more
doaj   +1 more source

Biosimilar tenecteplase versus alteplase in acute ischemic stroke: A real world study

open access: yesAnnals of Indian Academy of Neurology, 2023
Background and Purpose: There is an unmet need for a more effective thrombolytic agent in acute ischemic stroke (AIS) management. Various studies and meta-analysis suggest tenecteplase (TNK) as non-inferior over alteplase (rTPA).
Ayush Mohan   +11 more
doaj   +1 more source

Admission Tpe interval predicts reperfusion success in STEMI patients treated with fibrinolytic agents

open access: yesTürk Kardiyoloji Derneği Arşivi, 2020
Objective: Myocardial infarction is a leading cause of morbidity and mortality. Fibrinolytic administration is still a life-saving choice in ST-segment elevated myocardial infarction (STEMI), but the rate of successful reperfusion can be inconsistent ...
Ali Çoner   +4 more
doaj   +1 more source

The study of the pharmacological activity of thick extract from the leaves of Corylus avellana on the model of peripheral vascular thrombophlebitis in rabbit ear

open access: yesAktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2017
Creation of accessible domestic drug for the treatment and prevention of thrombotic venous damage, which would be able to adjust maximum range of disorders with minimal side effects, is actual direction of the pharmacology.
L. M. Maloshtan, A. S. Kalenichenko
doaj   +1 more source

Clinical profile of prosthetic heart valve thrombosis and outcome analysis of fibrinolytic therapy versus surgical management: A single-center experience

open access: yesHeart India, 2020
Context: The main aim of the study is to find out efficacy, outcomes, and complications of thrombolytic therapy and surgery for obstructive prosthetic heart valve thrombosis (PHVT).
Zeeshan Mansuri   +5 more
doaj   +1 more source

Does thrombolytic therapy harm or help in ST elevation myocardial infarction (STEMI) caused by the spontaneous coronary dissection? [PDF]

open access: yesVojnosanitetski Pregled, 2015
Introduction. Spontaneous coronary artery dissection (SCAD) is a very rare disease with poor prognosis. It mainly affects young women free of risk factors for coronary artery disease (CAD) and women during the peripartum period.
Jović Zoran   +6 more
doaj   +1 more source

Newer fibrinolytic agents in patients with acute myocardial infarction

open access: yes, 1986
Fibrinolytic agents with higher specificity for fibrin in the thrombi and little systemic activation of the fibrinolytic system have been developed and tested in preliminary clinical trials of patients with acute myocardial infarction.
E. Faioni, P. M. Mannucci
core   +1 more source

Home - About - Disclaimer - Privacy